1. Paper › Research › Not peer-reviewed
2. Published

   Modelling changes in first line antimalarial therapy

   Hughes, D. & Hughes, D. A., 1 Sept 2003.

   Research output: Contribution to conference › Paper

3. Published

   Orphan drug treatments: economic considerations

   Hughes, D. & Hughes, D. A., 1 Nov 2007.

   Research output: Contribution to conference › Paper

4. Published

   Patient compliance and persistence with prescribed medication: Measurement and health economic impact

   Hughes, D., Koncz, T., Hughes, D. A., Cleemput, I. & Annemans, L., 1 May 2004.

   Research output: Contribution to conference › Paper

5. Published

   Patient compliance and pharmacoeconomics

   Hughes, D. & Hughes, D. A., 1 Nov 2002.

   Research output: Contribution to conference › Paper

6. Published

   Patient compliance and pharmacoeconomics

   Hughes, D. & Hughes, D. A., 1 Oct 2001.

   Research output: Contribution to conference › Paper

7. Published

   Pharmacoeconomic evaluations in Ireland, Scotland and Wales: A Celtic perspective on pharmaceutical assessment

   Hughes, D., Hughes, D. A., Drummond, M., Tolley, K. & Ryan, M., 1 Oct 2007.

   Research output: Contribution to conference › Paper

8. Published

   Pharmacoeconomic models that incorporate non-compliance

   Hughes, D. & Hughes, D. A., 1 Jul 2004.

   Research output: Contribution to conference › Paper

9. Published

   Pharmacoeconomics appraisals by the all Wales medicines strategy group

   Hughes, D. & Hughes, D. A., 1 Jul 2004.

   Research output: Contribution to conference › Paper

10. Published

    Pharmacoeconomics in Wales: functions of the all Wales medicines strategy group

    Hughes, D. & Hughes, D. A., 1 Apr 2004.

    Research output: Contribution to conference › Paper

11. Published

    Pharmacoeconomics of pharmacogenetic testing: azathioprine

    Hughes, D., McAllister, R. & Hughes, D. A., 1 Apr 2004.

    Research output: Contribution to conference › Paper